Anand Bhaskar 4
4 · Summit Therapeutics Inc. · Filed May 1, 2025
Insider Transaction Report
Form 4
Anand Bhaskar
Chief Accounting Officer
Transactions
- Award
Stock Option (right to buy)
2025-04-29+75,000→ 75,000 totalExercise: $17.85Exp: 2035-01-12→ Common Stock (75,000 underlying) - Award
Stock Option (right to buy)
2025-04-29+600,000→ 600,000 totalExercise: $3.85Exp: 2034-04-02→ Common Stock (600,000 underlying)
Footnotes (3)
- [F1]Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest in four equal annual installments, with the first such installment occurring on December 31, 2025.
- [F2]Not applicable.
- [F3]Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest in four equal annual installments, with the first such installment occurring on January 12, 2026.